COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer

23/07/2018 - 07:02

NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]

MDxHealth (R) :

23/07/2018 - 07:02

MDxHealth (R) : MDxHealth reçoit une détermination de couverture locale finale positive de la part de Medicare pour l'utilisation de ConfirmMDx for Prostate Cancer

23/07/2018 - 07:02

Assurer une couverture à l'échelle nationale pour les patients Medicare IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, 23 juillet 2018 - MDxHealth SA (Euronext : MDXH.BR), a annoncé aujourd'hui que Palmetto GBA, un sous [...]

BeiGene Announces Preliminary Topline Results of Pivotal Trial in China for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma

22/07/2018 - 22:30

BEIJING, China and CAMBRIDGE, Mass., July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]

BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)

22/07/2018 - 22:30

Fast Track Designation Granted by U.S. FDA Enrollment Complete in Global Phase 3 Clinical Trial in WM CAMBRIDGE, Mass. and BEIJING, China, July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial- [...]

PotNetwork Holdings, Inc. Withdraws Form 10 due to Unrelated PCAOB Action Against Its Auditor – Refiling Planned

22/07/2018 - 21:57

FT LAUDERDALE, Fla., July 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company on July 20 th filed a request with the Securities and Exchange [...]

Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018

20/07/2018 - 23:23

SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“ Arcturus ” or the “ Company ”) (NASDAQ:ARCT), an RNA medicines company, today announced that it will hold an Annual and Extraordinary General [...]

Digirad Corporation to Release 2018 Second Quarter Financial Results on August 2, 2018

20/07/2018 - 22:30

Conference Call and Webcast Set for 11:00 a.m. EDT SUWANEE, Ga., July 20, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ:DRAD) will release financial results for its second quarter ended June 30, 2018, before the [...]

TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018

20/07/2018 - 22:15

WALTHAM, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce second-quarter 2018 financial results on Thursday, August 2, 2018, after the close of the U.S. financial markets. TESARO’s [...]

Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

20/07/2018 - 22:05

SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date

20/07/2018 - 22:01

SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter [...]

Dentsply Sirona to Host Second Quarter 2018 Conference Call on August 7th

20/07/2018 - 20:00

YORK, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Tuesday, August [...]

Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update

20/07/2018 - 19:06

CANTON, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 8, 2018 at 4:30 p.m [...]

Major shareholder notification – T. Rowe Price Group, Inc.

20/07/2018 - 16:53

Announcement NO. 30 July 20, 2018 Major shareholder notification – T. Rowe Price Group, Inc. GN Store Nord has received information that T. Rowe Price Group, Inc. has decreased its holdings of GN shares. T. Rowe Price [...]

FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation

20/07/2018 - 16:45

CAMBRIDGE, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- - Approval of TIBSOVO ® was Based on Phase 1 Study Results, Including Rate and Duration of Complete Remission (CR) and CR with Partial Hematologic Recovery (CRh) and [...]

Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer

20/07/2018 - 16:30

SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based clinical-stage company translating best-in-class gene engineering technologies into lifesaving cell therapies, today [...]

Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors

20/07/2018 - 13:30

Medical device and biopharma drug development, M&A experience enhance Arch FRAMINGHAM, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of the AC5 [...]

T2 Biosystems Announces 2018 Second Quarter Financial and Operational Results Release and Conference Call Date

20/07/2018 - 13:00

LEXINGTON, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock

20/07/2018 - 15:10

DEVON, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) today announced the pricing of an underwritten public offering of 4,062,500 shares of its common stock at a price of $8.00 per [...]